A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes. (2017)

First Author: Mercader JM
Attributed to:  Targeting etiologic molecular mechanisms to treat human diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/db17-0187

PubMed Identifier: 28838971

Publication URI: http://europepmc.org/abstract/MED/28838971

Type: Journal Article/Review

Volume: 66

Parent Publication: Diabetes

Issue: 11

ISSN: 0012-1797